LIfT BioSciences announces breakthrough preclinical data demonstrating dual mode of action
LIfT BioSciences announces breakthrough preclinical data demonstrating the dual mode of action commonly believed necessary for curing solid
Mar 21, 2023
LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership
GMP N-LIfT being produced for forthcoming clinical trials LONDON, UK and MUNICH, Germany – February 16th, 2023. LIfT BioSciences, a...
Feb 16, 2023
LIfT BioSciences investors increase investment in LIfT and Johnson and Johnson welcomes LIfT into JL
London, 19 December 2022 – LIfT BioSciences is pleased to announce that it’s lead investor, Starbloom Capital, has provided further...
Dec 19, 2022
Alex Blyth's Interview about how LIfT came to be, and why we need to move on from mouse models
The Business of Biotech interviews serial inventor and entrepreneur Alex Blyth who had long held interests in health and science, but...
Nov 7, 2022
LIfT at The Rejuvenation Summit
LIfT BioSciences presented at Forever Healthy Foundation's Rejuvenation Summit In Berlin. Alex Blyth, LIfT's CEO, presented on the links...
Oct 21, 2022
